Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare Lebrikizumab (Ebglyss) and UPADACITINIB (Rinvoq) — clinical data, side effects, and patient experiences.
Ebglyss · Biologic (IL-13 Inhibitor)
How it works
High-affinity monoclonal antibody that selectively binds IL-13 and prevents formation of the IL-13Rα1/IL-4Rα heterodimer signalling complex.
Approved for
Rinvoq · JAK Inhibitor
How it works
12.1 Mechanism of Action Upadacitinib is a Janus kinase (JAK) inhibitor. JAKs are intracellular enzymes which transmit signals arising from cytokine or growth factor-receptor inter...
Approved for
Estimated frequency (%) based on clinical trial data
Based on 22 Reddit discussions
Lebrikizumab
29%
positive
7 threads
UPADACITINIB
60%
positive
15 threads
% of discussions mentioning each side effect
7 Reddit threads analysed for Lebrikizumab
Overall Sentiment
Mixed
Comparison Threads
1
Avg Post Score
6 upvotes
Most discussed side effects in community
Threads directly comparing Lebrikizumab to other medications
I’ve been on Adbry for almost 11 months now and I’ve seen quite good improvement during the Sommer months but now it’s winter and it doesn’t seem to be really effective. I read all the studies and it’s generally mentioned that Lebrikizumab has a better efficacy and I wonder if anyone has tried both
This content is intended for US-based consumers and HCPs. Dr. April Armstrong is Professor and Chief of Dermatology at UCLA, and an internationally recognized expert in inflammatory skin diseases. She has led over 150 clinical trials and published more than 500 scientific articles. Her federally fun
Hi, hope you're all well. I'd just like to give you my experience with dupilumab so far and get your thoughts if that's ok? I'm both lucky and unlucky with my eczema. Unlucky in the sense that I have 100% coverage. Without treatment, every square inch of my skin is very dry, becomes inflamed a
HELLO FROM THE UK 21 YEARS OLD i’ve been suffering with eczema and recently i’ve had to be hospitalised with staph infection , its been cleared from my bloodstream but the staph seems to not stop growing on my face and infecting my face, my eczema is controlled and well but the staph seems to be mak
HELLO FROM THE UK 21 YEARS OLD i’ve been suffering with eczema and recently i’ve had to be hospitalised with staph infection , its been cleared from my bloodstream but the staph seems to not stop growing on my face and infecting my face, my eczema is controlled and well but the staph seems to be mak
Hi there! For context, I've (23F) been struggling with severe atopic dermatitis pretty much my whole life with some pauses due to medications I've taken or random changes my body has had. During the last 2 years i was on a trial for lebrikizumab which was going pretty okay, and for the last ≈10 mont
I’m being taken off of Dupixent due to severe facial flares and eye issues, I’m now going onto Lebrikizumab. Any experiences with this switch?
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
15 Reddit threads analysed for UPADACITINIB
Overall Sentiment
Slightly positive
Comparison Threads
0
Avg Post Score
29 upvotes
Most discussed side effects in community
For context: for pretty much all of last year over 80% of my body was covered in eczema rash. It was so severe I couldn't use the shower and had to either take baths or wash myself in the sink. My scalp was constantly peeling and I was *always* itchy. While my skin would get better in summer, it was
#Earnings Advance Auto Parts (AAP) Q4 Adj. EPS USD 1.17 vs. Exp. USD 1.13, revenue USD 2.1bln vs. Exp. USD 2.11bln, SSS increased by 3.4%. Sees FY19 revenue USD 9.65bln-9.8bln vs. Exp. USD 9.78bln. (Newswires) Continental Resources (CLR) Q4 Adj. EPS USD 0.54 vs. Exp. USD 0.62, revenue USD 1.15
Hey everyone! I just wanted to provide some sort of update having been on Upadacitinib for just over a month. My eczema is gone and I no longer need to take cold showers and I don't even need to moisturise after showers. My skin looks healthy and clear it is so surreal. This medication is not a ste
Welcome back to this week's newsflash 1. Vedolizumab, a medication used for ulcerative colitis, shows promise in treating chronic pouchitis as well. A new study found it to be effective in reducing ulcer count and inducing mucosal healing. Do you want to know [more](https://www.healio.com/news/gastr
I am interested in participating in a clinical trial. I am leaning towards the 3 mentioned in the title, though I would love to hear about any others that seem promising. I am hoping there will be phase 3 trials in my area some time in the first half of 2018 for ABT-494 and PF-04965842. Phase 3 for
About 80% of my body was covered when I went to the dermatologist, so he sent me to hospital for inpatient treatment for 5 days. I did a paraffin bath -> topical steroid -> wet wrap -> emollient treatment twice a day and everything has cleared up. I've been given a metric tonne of moisturiz
Almost a year ago, after years of worsening Atopic Dermatitis, i said enough is enough, and decided to buy Upadacitinib, a JAK inhibitor originally used for rheumatoid arthritis, after reading about very promising clinical trials for AD. When i posted about it many of you guys were surprised about
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
Lebrikizumab is a Biologic (IL-13 Inhibitor), while UPADACITINIB belongs to the JAK Inhibitor class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles. Lebrikizumab is administered via Subcutaneous, whereas UPADACITINIB uses Oral. Route of administration can affect onset of action and patient adherence.
Lebrikizumab carries 2 FDA warnings. UPADACITINIB carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.